Arecor Therapeutics scientist hopeful that artificial pancreas "edging closer"

Digital Asset Direct by Arecor Therapeutics PLC

London, UK | November 15, 2022 07:43 AM Eastern Standard Time

Arecor Therapeutics (AIM:AREC) CEO Sarah Howell & scientist Rafic Sukar visited the Proactive London studio on World Diabetes Day to provide an update on the work they're doing to make life easier for those suffering with the disease. Sukar was diagnosed with type 1 diabetes as an infant and now works on developing new treatments.

Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Why News Direct

For Public Relations For Investor Relations Testimonials

About us Features News Hub

Resources

Press Blog

Why News Direct For Public Relations For Investor Relations Testimonials

What We Offer Collaborative Content Studio Advanced News Release Capability Standalone Multimedia Distribution Industry-Leading Security Unsurpassed Global Reach Actionable Analytics Synergistic PR Solutions

Pricing About us News Hub

Resources Blog Press